Browse studies
Find your next paid study
4 recruiting studies matching your filters
Observational
Beating Lung Cancer in Ohio (BLCIO) Protocol
This randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The…
Cigarette SmokerCurrent SmokerLung Adenocarcinoma+2 more
Estimated
~$10 – $6,250
Ohio State University Comprehensive Cancer CenterNCT03199651
Phase 1
A Phase 1/2, Open-label Study of PD-1 Knockout Tumor-infiltrating Lymphocytes (IOV-4001) in Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
This is a study to investigate the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced no…
Unresectable MelanomaMetastatic MelanomaStage III Non-small Cell Lung Cancer+1 more
Estimated
~$10 – $8,750
Iovance Biotherapeutics, Inc.NCT05361174
Observational
Patient-centered, Optimal Integration of Survivorship and Palliative Care
The goal of this study is to develop and test the feasibility of a supportive care model (POISE) for patients with metastatic Non-small Cell Lung Cancer (NSCLC…
Stage IV Non-small Cell Lung CancerTargeted TherapyNonsmall Cell Lung Cancer+5 more
Estimated
~$10 – $6,250
Massachusetts General HospitalNCT04900935
Phase 1
Clinical Trial of CD40L-augmented Tumor Infiltrating Lymphocytes (CD40L TIL) for Patients With Oncogene-Driven Advanced Non-Small Cell Lung Cancer (NSCLC)
To determine the effect of a special preparation of cells, called tumor-infiltrating lymphocytes (TIL) stimulated with CD40L, when given with the drug nivoluma…
Non Small Cell Lung CancerStage IV Non-small Cell Lung CancerRecurrent Non Small Cell Lung Cancer
Estimated
~$10 – $6,250
H. Lee Moffitt Cancer Center and Research InstituteNCT05681780